First Eagle Investment's BBNX Position Overview
First Eagle Investment (via First Eagle Investment Management, LLC) currently holds 253,702 shares of Beta Bionics, Inc. (BBNX) worth $7.73 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, First Eagle Investment has initiated a new position in BBNX, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 20,500 shares.
Analysis based on 13F filings available since 2013 Q2
First Eagle Investment's Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by First Eagle Investment
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +20,500 | Add 8.79% | 253,702 | $30.47 |
| Q3 2025 | +233,202 | New Buy | 233,202 | $19.87 |
First Eagle Investment's Beta Bionics Investment FAQs
First Eagle Investment first purchased Beta Bionics, Inc. (BBNX) in Q3 2025, acquiring 233,202 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
First Eagle Investment has held Beta Bionics, Inc. (BBNX) for 2 quarters since Q3 2025.
First Eagle Investment's largest addition to Beta Bionics, Inc. (BBNX) was in Q3 2025, adding 233,202 shares worth $4.63 M.
According to the latest 13F filing for Q4 2025, First Eagle Investment's firm, First Eagle Investment Management, LLC, owns 253,702 shares of Beta Bionics, Inc. (BBNX), valued at approximately $7.73 M.
As of the Q4 2025 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.01% of First Eagle Investment's publicly disclosed stock portfolio, making it one of their key holdings.
First Eagle Investment's peak holding in Beta Bionics, Inc. (BBNX) was 253,702 shares, as reported at the end of Q4 2025.